What is the Role for Risk Adjustment and Risk Mitigation?
Intense national debates about health policy have focused on instability in the individual market, including health insurance exchanges under the Patient Protection and Affordable Care Act. Risk adjustment and other risk-mitigation measures are essential tools for stabilizing competitive markets and lowering premiums. To explore practical policy approaches that can help such tools achieve these goals in the current individual market or the market as it may operate under major federal changes, the Urban Institute and the American Action Forum recently convened a daylong roundtable summit of leading national experts from academia, industry, and the actuarial community.
Join us in a discussion of that summit’s significant findings, as presented in an issue brief by researchers from the Urban Institute and the American Action Forum. The issue brief will be released in tandem with the event.
- M. Kate Bundorf, Associate Professor of Health Research and Policy, Stanford University School of Medicine
- Stan Dorn, Senior Fellow, Health Policy Center, Urban Institute
- Douglas Holtz-Eakin, President, American Action Forum
- John Kaelin, Senior Adviser, Centene Corporation; Member, Dean’s Council, George Washington University School of Public Health
- Timothy Layton, Assistant Professor of Health Care Policy, Department of Health Care Policy, Harvard Medical School
- Sarah Rosen Wartell, President, Urban Institute
- Cori Uccello, Senior Health Fellow, American Academy of Actuaries